Corporate News 12-Mar-24
Suven Pharmaceuticals receives revision in credit ratings
Suven Pharmaceuticals announced that CRISIL has assigned the rating 'CRISIL A+/ Watch Positive (placed on rating watch with positive implications) / CRISIL A1+ (reaffirmed) for bank facilities of the company.
Previous News
Suven Pharmaceuticals to conduct board meeting
( Corporate News - 31-Jan-24 12:06 )
Suven Pharmaceuticals fixes record date for final dividend
( Market Beat - Reports 08-Jun-21 16:05 )
Suven Pharmaceuticals to table results
( Corporate News - 03-Aug-23 14:27 )
Board of Suven Pharmaceuticals approves acquisition of Casper Pharma
( Corporate News - 05-Apr-22 13:18 )
Suven Pharmaceuticals consolidated net profit declines 56.60% in the December 2023 quarter
( Results - Announcements 06-Feb-24 07:34 )
Board of Suvan Pharmaceuticals recommends Interim Dividend
( Corporate News - 11-Feb-21 10:52 )
Volumes jump at Suven Pharmaceuticals Ltd counter
( Hot Pursuit - 12-Jan-22 11:00 )
Suven Pharmaceuticals to conduct board meeting
( Corporate News - 09-Aug-21 12:13 )
Volumes spurt at Avanti Feeds Ltd counter
( Hot Pursuit - 14-Sep-23 14:30 )
Volumes soar at Emami Ltd counter
( Hot Pursuit - 31-May-21 11:39 )
Board of Suvan Pharmaceuticals recommends special dividend
( Corporate News - 10-May-22 15:15 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top
